Search from 1167 projects:
A Phase 3 Double-blinded, Two-arm Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) versus Placebo as Adjuvant herapy in Participants ith Hepatocellular Carcinoma and Complete Radiological Response after Surgical esection or Local...
Clinical Studies - May 1, 2019 - May 1, 2026
Ongoing
Project leader: Semela David Members: Stillhard Roman
We use cookies and tracking technologies according to our privacy policy to provide you with the best possible web experience. To the privacy policy